Arizona Arthritis and Rheumatology Research, PLLC
Rebecca Martinez has extensive experience in clinical research and operations management, currently serving as the Director of Clinical Research and Operations Manager at Arizona Arthritis and Rheumatology Research, PLLC since June 2012. Previously, Martinez was a Clinical Research Coordinator at Arizona Arthritis & Rheumatology Research and worked as a Formulation Chemist at Covance, where responsibilities included ensuring compliance with GLP and SOP guidelines and preparing laboratory formulations. Additionally, early career experience includes a position as a Student Researcher at Biodesign and a Retail Associate at Campus Corner. Rebecca attained a Master of Science in Clinical Research Management from Arizona State University in 2019, after earning a Bachelor's degree in Biochemistry from the same institution in 2010.
This person is not in any teams
Arizona Arthritis and Rheumatology Research, PLLC
Arizona Arthritis & Rheumatology Research (AARR) remains at the forefront of rheumatologic care by participating in clinical trials of new rheumatologic drugs and the enrollment and supervision of patients who qualify and who may be in need of other potentially effective therapies. In a clinical drug trial, medications are supplied at no cost to participating patients. Clinical trials may offer benefit to patients who have not responded to conventionally available treatments. As the research wing of Arizona Arthritis & Rheumatology Associates (AARA), we keep involved in the valuable process of new drug development. As long as people continue to suffer from the damage of immunologic illness and musculoskeletal disorders, medical scientists and pharmaceutical and device companies will forge ahead for the next advancement in treatment. Only real people with these disorders can move this science ahead for themselves and others who may suffer these disorders in the future. We encourage our patients whenever appropriate to consider contributing to medical science through enrollment in FDA supervised clinical trials.